PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-01

Study Completion Date

2018-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall goal of this project is to investigate the diagnostic performance of integrated F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) and Dual Energy CT (DECT) imaging in determining the thoracic nodal status of small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC), and its impact on target volume delineation for image guided radiation therapy (IGRT) planning.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

NCT00004138

Lung Cancer

COMPLETED NA

PET CT Re-Planning NSCLC (4DCT-PET)

NCT03403127

Lung Cancer Non-Small Cell Lung Cancer

COMPLETED NA

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

NCT02325349

Advanced Head and Neck Carcinoma Advanced Non-small Cell Lung Carcinoma

TERMINATED PHASE2

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

NCT01109953

Lung Cancer

TERMINATED

PET-CT Imaging With PCD-CT

NCT07242690

Head and Neck Cancer (H&N)

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PET CT

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

To be eligible for the study: (All answers must be "YES" for subject to be eligible.)

1. Subject must have a suspected SCLC or NSCLC.
2. Subject must be 18-90 years of age.
3. Subject must have been referred for a clinically indicated PET-CT.
4. Subject must provide written informed consent prior to any study-related procedures being performed.
5. Subject must be willing to comply with all clinical study procedures.

Exclusion Criteria

The presence of the following excludes subjects from the study: (All answers must be "NO" for subject to be eligible.)

1. Subject is a pregnant or nursing female. Exclude the possibility of pregnancy:

* By testing (serum or urine βHCG) within 24 hours before contrast agent administration, or
* By surgical sterilization, or
* Post-menopausal, with minimum one (1) year history without menses.
2. Subject has impaired renal function (eGFR\<30 mL/min).
3. Subject has an acute psychiatric disorder or is cognitively impaired.
4. Subject is using or is dependent on substances of abuse.
5. Subject is unwilling to comply with the requirements of the protocol.
6. Subject has an allergy against iodinated contrast agents and cannot be premedicated.
7. Subject is in acute unstable condition.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No